Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 101
Filter
1.
Turk J Ophthalmol ; 54(1): 46-48, 2024 Feb 22.
Article in English | MEDLINE | ID: mdl-38385320

ABSTRACT

A 56-year-old man was referred to our clinic for unilateral nodular scleritis unresponsive to systemic corticosteroids. A localized, nodular hyperemia on the nasal bulbar conjunctiva surrounding a central cyst-like lesion together with vascular engorgement was observed on slit-lamp examination of the left eye. No abnormal fundoscopic findings were noted. Surgical exploration revealed an embedded episcleral brown colored, soft to touch, splinter-like organic foreign body (FB) which was confirmed by the histopathological examination. Nodular hyperemia resolved during the postoperative follow-up period, and mild scar tissue accompanied by scleral thinning developed in the left nasal bulbar conjunctiva. Ocular injury associated with FBs may cause significant ocular morbidity depending on the nature and location of the FB. Severe visual disability may occur if left untreated. Subconjunctival FBs are rare and may present with a clinical picture mimicking episcleritis or scleritis. History of trauma involving a FB should always be assessed for an accurate differential diagnosis and appropriate management of patients with anterior scleritis.


Subject(s)
Foreign Bodies , Hyperemia , Scleritis , Male , Humans , Middle Aged , Scleritis/diagnosis , Hyperemia/drug therapy , Sclera , Glucocorticoids/therapeutic use , Foreign Bodies/drug therapy
2.
J Feline Med Surg ; 25(10): 1098612X231201808, 2023 10.
Article in English | MEDLINE | ID: mdl-37906200

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate and describe 13 cases in which a pet piller broke during the administration of medication, and the tip was accidentally ingested by the cat. METHODS: A total of 15 presentations to the clinic were identified in a private practice database involving 13 cats in which the silicone tip broke. Two of these cats ingested foreign bodies on two separate occasions. Routine radiographic examination enabled the identification of silicone tips in all animals. On 2/15 occasions, the cats did not receive an emetic drug. Intramuscular xylazine (0.2 mg/kg) and dexmedetomidine (6 µg/kg) were administered to 12/15 and 1/15 cats, respectively. RESULTS: The cats were aged 3-17 years (mean age 11.00 ± 4.35 years). Vomiting occurred in 13 cats that received alpha-2 adrenoceptor agonists, although the silicone tip was recovered in only five occurrences. In 9/15 occurrences, endoscopy was performed under general inhalation anesthesia, and the silicone tip was successfully removed. Natural elimination occurred in only one case. CONCLUSIONS AND RELEVANCE: The use of pet pillers with detachable silicone tips increases the risk of accidental foreign body ingestion by animals. Therefore, guidelines regarding safety standards for manufacturing would be beneficial. No cat in this series developed clinical signs related to the ingestion of the piller tip, probably because of the quick presentation by the owners and early intervention, including endoscopic retrieval. Surgical intervention was not required in any case, including one in which the foreign body was lodged within the small intestine before being passed naturally by the cat.


Subject(s)
Cat Diseases , Foreign Bodies , Cats , Animals , Retrospective Studies , Vomiting/veterinary , Eating , Foreign Bodies/veterinary , Foreign Bodies/drug therapy , Foreign Bodies/surgery , Silicones/therapeutic use , Cat Diseases/chemically induced
3.
Article in English | MEDLINE | ID: mdl-37436922

ABSTRACT

OBJECTIVE: To determine whether administration of antiemetic medication to dogs and cats with gastrointestinal foreign body obstruction (GIFBO) delays time to definitive care (surgery or endoscopy) and increases the risk of complications. DESIGN: Retrospective study (January 2012-July 2020). SETTING: Private referral center. ANIMALS: Five hundred and thirty-seven (440 dogs and 97 cats). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Medical records of dogs and cats with GIFBO were reviewed for antiemetic administration at the onset of clinical signs, time from onset of clinical signs to first intervention and definitive care, GIFBO-related complications, and length of hospitalization. Antiemetics were prescribed for 200 of 537 patients (158 dogs, 42 cats). Antiemetic administration was associated with an increased time between the onset of clinical signs and definitive care (3.2 days [95% confidence interval, CI, 2.8-3.5] vs. 1.6 days [95% CI, 1.4-2.0]; P < 0.001) but not with GIFBO-associated complications (P = 0.45). Antiemetic administration was associated with an increased length of hospitalization (1.6 days [95% CI, 1.4-1.7] vs. 1.1 days [95% CI, 1.1-1.2]; P < 0.001). A longer duration of clinical signs prior to intervention was associated with GIFBO-related complications (P < 0.001) regardless of antiemetic administration. CONCLUSIONS: Antiemetic administration in patients with GIFBO was associated with increased time to definitive care and length of hospitalization but not GIFBO-associated complications. Antiemetics are not inherently contraindicated in patients for whom GIFBO is a differential, but clients should be counseled to monitor for progression of clinical signs and follow-up accordingly.


Subject(s)
Antiemetics , Cat Diseases , Dog Diseases , Foreign Bodies , Humans , Cats , Dogs , Animals , Antiemetics/therapeutic use , Retrospective Studies , Cat Diseases/etiology , Dog Diseases/chemically induced , Dog Diseases/drug therapy , Foreign Bodies/complications , Foreign Bodies/veterinary , Foreign Bodies/drug therapy
4.
Am J Health Syst Pharm ; 80(7): 430-434, 2023 03 21.
Article in English | MEDLINE | ID: mdl-36566498

ABSTRACT

PURPOSE: Medication use may affect imaging results. In this case study, we report a case of lanthanum ingestion resulting in imaging consistent with ingested metallic foreign bodies. SUMMARY: Hyperphosphatemia affects most patients with end-stage renal disease (ESRD) and is associated with morbidity and mortality. Lanthanum carbonate reduces daily phosphate absorption and is indicated as a non-calcium-based phosphate binder in patients with ESRD. A 58-year-old man with a medical history of stage 5 chronic kidney disease was admitted to the intensive care unit (ICU) for hyperkalemia and acute respiratory failure after a missed dialysis session. He required vasopressors, intubation, and continuous renal replacement therapy. Admission imaging demonstrated several ingested metallic foreign bodies within the colon. There was consideration of colorectal surgery and gastroenterology consultation. On the initial medication reconciliation, no medications that would have the radiographic appearance of ingested metallic foreign bodies were identified. On further review of prescription data available through the electronic medical record, it was noted that the patient had recently filled a prescription for lanthanum despite its apparent discontinuation on a previous admission. After interviewing the patient's wife, it was confirmed that the patient had continued taking lanthanum and that he was swallowing it whole and not chewing it. No consultations or interventions were performed, and the metallic foreign bodies were no longer present on further imaging after a period of 35 days. CONCLUSION: Escalation of care was avoided in this patient due to the performance of diligent medication reconciliation and recognition of the impact of lanthanum ingestion on imaging.


Subject(s)
Foreign Bodies , Hyperphosphatemia , Kidney Failure, Chronic , Male , Humans , Middle Aged , Lanthanum/adverse effects , Critical Illness/therapy , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , Renal Dialysis , Hyperphosphatemia/chemically induced , Hyperphosphatemia/complications , Phosphates/therapeutic use , Foreign Bodies/complications , Foreign Bodies/diagnostic imaging , Foreign Bodies/drug therapy , Eating
5.
Ocul Immunol Inflamm ; 31(7): 1548-1550, 2023 Sep.
Article in English | MEDLINE | ID: mdl-36084302

ABSTRACT

A 55-year-old lady with bamboo stick injury to her right eye suffered corneal laceration with retained wooden foreign body in the anterior chamber. In the first-sitting corneal laceration repair, lens aspiration with foreign body removal was done. Two days later, she developed signs and symptoms of endophthalmitis for which pars plana vitrectomy with intravitreal antibiotic injection was done. Smear examination of vitreous sample revealed the presence of Gram-positive cocci in pairs and short chains on Gram's stain on the same day. Confluent white, moist, and alpha-hemolyticus bacterial colonies appeared over the inoculum on blood agar and chocolate plates on the next day, which later was identified as Globicatella sanguinis by VITEK-2 compact system. To our knowledge, this is the second reported case of Globicatella-related endophthalmitis; the outcome was favourable in the incumbent case owing to an early intervention and isolate being susceptible to vancomycin.


Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Foreign Bodies , Lacerations , Humans , Female , Middle Aged , Anti-Bacterial Agents/therapeutic use , Lacerations/drug therapy , Lacerations/surgery , Endophthalmitis/microbiology , Vitrectomy , Foreign Bodies/drug therapy , Foreign Bodies/surgery , Eye Infections, Bacterial/microbiology
6.
J Pain ; 23(12): 2070-2079, 2022 12.
Article in English | MEDLINE | ID: mdl-36087907

ABSTRACT

Although numerous studies have described botulinum toxin type A (BTX-A) efficacy against trigeminal neuralgia (TN), the underlying cellular mechanisms remain unclear. We have investigated cellular mechanisms that mediate the antinociceptive effect of BTX-A in a rodent model of TN produced by compression of the trigeminal nerve root (TNR). Anesthetized male Sprague-Dawley rats were fixed in a stereotaxic instrument and compression of the TNR was then achieved with a 4% agar solution. This model produced a significant mechanical allodynia and increased the expression of hypoxia-inducible factor (HIF)-1α and cytokines levels including interleukin (IL)-1ß, IL-6, and tumor necrosis factor (TNF)-α in the trigeminal ganglion (TG) by postoperative day (POD) 7. Single or double treatments with a high BTX-A dose (3 U/kg) led to significantly prolonged antinociceptive effects. Furthermore, a single treatment with BTX-A (3 U/kg) significantly suppressed the upregulation of HIF-1α expression and IL-1ß, IL-6, and TNF-α concentrations in the TG. Intraganglionic injection of PX-12, a HIF-1α inhibitor, led to significant anti-allodynic effects and lowered the IL-1ß, IL-6, and TNF-α levels in the TG. These findings indicate that the antinociceptive effect of BTX-A is mediated via HIF-1α associated cytokines modulation in the TG and is therefore a potentially relevant treatment strategy for TN. PERSPECTIVE: The antinociceptive properties of BTX-A in a rat model of trigeminal neuralgia are mediated through the regulation of the HIF-1α associated cytokine pathway in the trigeminal ganglion. BTX-A is therefore a potentially effective treatment strategy for trigeminal neuralgia.


Subject(s)
Botulinum Toxins, Type A , Foreign Bodies , Trigeminal Neuralgia , Male , Rats , Animals , Botulinum Toxins, Type A/pharmacology , Trigeminal Neuralgia/drug therapy , Rats, Sprague-Dawley , Rodentia , Tumor Necrosis Factor-alpha , Interleukin-6 , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Inflammation/drug therapy , Cytokines , Analgesics/pharmacology , Analgesics/therapeutic use , Foreign Bodies/drug therapy
7.
Crit Rev Microbiol ; 48(5): 624-640, 2022 Sep.
Article in English | MEDLINE | ID: mdl-34879216

ABSTRACT

Biomaterial-associated infections (BAIs) are an increasing problem where antibiotic therapies are often ineffective. The design of novel strategies to prevent or combat infection requires a better understanding of how an implanted foreign body prevents the immune system from eradicating surface-colonizing pathogens. The objective of this review is to chart factors resulting in sub-optimal clearance of Staphylococcus aureus bacteria involved in BAIs. To this end, we first describe three categories of bacterial mechanisms to counter the host immune system around foreign bodies: direct interaction with host cells, modulation of intercellular communication, and evasion of the immune system. These mechanisms take place in a time frame that differentiates sterile foreign body reactions, BAIs, and soft tissue infections. In addition, we identify experimental interventions in S. aureus BAI that may impact infectious mechanisms. Most experimental treatments modulate the host response to infection or alter the course of BAI through implant surface modulation. In conclusion, the first week after implantation and infection is crucial for the establishment of an S. aureus biofilm that resists the local immune reaction and antibiotic treatment. Although established and chronic S. aureus BAI is still treatable and manageable, the focus of interventions should lie on this first period.


Subject(s)
Foreign Bodies , Staphylococcal Infections , Anti-Bacterial Agents/therapeutic use , Biocompatible Materials/adverse effects , Biofilms , Foreign Bodies/drug therapy , Foreign-Body Reaction/drug therapy , Foreign-Body Reaction/etiology , Humans , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics
9.
Int Immunopharmacol ; 96: 107801, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34162162

ABSTRACT

Cystatins are natural inhibitors of cysteine peptidases that are found practically in all living organisms. CaneCPI-5 is a sugarcane cystatin with inhibitory activity against human cathepsins B, K and L, which are cysteine proteases highly expressed in a variety of pathological conditions, usually marked by persistent inflammation and processing of the extracellular matrix. This work evaluated the effects of daily administration of the recombinant cystatin CaneCPI-5 [0.01, 0.1 or 1.0 µg in 10 µL of Phosphate-Buffered Saline (PBS)] on the inflammatory, angiogenic and fibrogenic components during chronic inflammatory response induced by subcutaneous sponge implants. The anti-inflammatory effect of treatment with CaneCPI-5 was confirmed by reduction of the levels of the pro-inflammatory mediators TNF-α, CXCL1 and CCL2/JE/MCP-1, as well as the activity of the myeloperoxidase and n-acetyl-ß-D-glucosaminidase. Treatment with CaneCPI-5 promoted angiogenesis in the implants, increasing the production of cytokines VEGF and FGF and the formation of new blood vessels. Finally, the administration of the recombinant cystatin favored the production of the pro-fibrogenic cytokine TGF-ß1 and collagen deposition next to the implants. Together, these results show the potential therapeutic application of CaneCPI-5 as an anti-inflammatory agent, capable of favoring angiogenesis and fibrogenesis processes, necessary for tissue repair.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Collagen/metabolism , Cystatins/therapeutic use , Foreign Bodies/drug therapy , Neovascularization, Physiologic/drug effects , Plant Proteins/therapeutic use , Animals , Anti-Inflammatory Agents/pharmacology , Cystatins/genetics , Cystatins/pharmacology , Cytokines/immunology , Disease Models, Animal , Down-Regulation/drug effects , Foreign Bodies/metabolism , Male , Mice, Inbred C57BL , Plant Proteins/genetics , Plant Proteins/pharmacology , Recombinant Proteins/pharmacology , Recombinant Proteins/therapeutic use , Saccharum , Skin/blood supply , Skin/drug effects , Skin/immunology , Skin/metabolism , Surgical Sponges
10.
Wilderness Environ Med ; 32(2): 235-239, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33839016

ABSTRACT

Penetrating injuries from marine animals are rare events; however, published case reports have detailed critical injuries including death occurring as a result of such incidents. We present a case of a marine penetrating injury to the right posterolateral shoulder of a 10-y-old boy. The patient underwent open surgical debridement and a course of oral antibiotics before returning to normal function. Clinicians should have an appreciation of various clinical patterns of marine penetrating wounds, the need for prompt imaging to exclude foreign bodies, and appropriate antibiotics to cover gram-negative bacteria and Vibrio species, which are commonly found in marine-related injuries.


Subject(s)
Foreign Bodies , Wounds, Penetrating , Animals , Anti-Bacterial Agents/therapeutic use , Foreign Bodies/diagnostic imaging , Foreign Bodies/drug therapy , Foreign Bodies/surgery , Humans , Male , Wounds, Penetrating/diagnosis , Wounds, Penetrating/surgery
11.
Eur Rev Med Pharmacol Sci ; 24(21): 11315-11322, 2020 11.
Article in English | MEDLINE | ID: mdl-33215451

ABSTRACT

OBJECTIVE: To systematically evaluate the anesthetic effect and safety of sevoflurane combined with propofol in removing tracheal foreign bodies in children. MATERIALS AND METHODS: PubMed, EMbase, The Cochrane Library, China Biomedicine Database, China National Knowledge Internet, WanFang Data, and VIP databases were searched. Randomized controlled trials (RCTs) of sevoflurane combined with propofol for anesthesia during tracheal foreign body extraction in children were collected. The retrieval time was from the establishment of the database to April 10, 2019. RevMan 5.3 software was used for meta-analysis after two researchers independently screened the literature, extracted data, and evaluated the risk bias included in the study. RESULTS: Seven RCTs involving 473 patients were included. Meta-analysis showed that the time of loss of consciousness significantly reduced (MD=-38.27, 95% CI (-41.77, -34.77), p < 0.00001) and the recovery time significantly reduced (MD=-12.29, 95% CI (-2.77, -1.80), p < 0.00001) in the sevoflurane combined with propofol group compared with the control group. In terms of safety, the heart rate was slower [MD=-11.00, 95% CI (-21.64, -0.36), p=0.04 < 0.05] and the incidence of cough and breath holding was lower [MD=0.38, 95% CI (0.19, 0.78), p=0.008] in the sevoflurane combined with propofol group than in the control group. However, no significant difference in respiratory rate and SPO 2 < 90% was found between the two groups (p > 0.05). CONCLUSIONS: Sevoflurane combined with propofol is worth popularizing because of its high anesthetic effect and safety in the removal of tracheal foreign bodies in children. However, given the limited quantity and quality of the included studies, the above conclusions need to be verified by high-quality studies.


Subject(s)
Anesthetics/pharmacology , Foreign Bodies/drug therapy , Propofol/pharmacology , Sevoflurane/pharmacology , Trachea/drug effects , Anesthetics/administration & dosage , Anesthetics, Inhalation , Anesthetics, Intravenous , Child , Drug Therapy, Combination , Humans , Propofol/administration & dosage , Randomized Controlled Trials as Topic , Sevoflurane/administration & dosage
12.
Pan Afr Med J ; 36: 140, 2020.
Article in English | MEDLINE | ID: mdl-32849995

ABSTRACT

Liver abscess secondary to a migrated ingested foreign body is an uncommon condition where early diagnosis helps management and improves prognosis. Abscess drainage with removal of the foreign body is the recommended management. We report the successful management of a patient with a liver abscess from a migrated fishbone that was treated medically with the foreign body left in situ.


Subject(s)
Bone and Bones , Foreign Bodies/complications , Foreign-Body Migration/complications , Liver Abscess/etiology , Seafood , Abdominal Pain/diagnosis , Abdominal Pain/drug therapy , Abdominal Pain/etiology , Animals , Anti-Bacterial Agents/administration & dosage , Diagnosis, Differential , Drug Therapy, Combination , Female , Foreign Bodies/diagnosis , Foreign Bodies/drug therapy , Foreign-Body Migration/diagnosis , Foreign-Body Migration/drug therapy , Humans , Liver Abscess/diagnosis , Liver Abscess/drug therapy , Metronidazole/administration & dosage , Middle Aged , Piperacillin, Tazobactam Drug Combination/administration & dosage , Tomography, X-Ray Computed
13.
Emerg Med J ; 37(7): 434-436, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32366615

ABSTRACT

BACKGROUND: Thirteen episodes of oesophageal food impaction (EFI) per 100 000 people present to a medical setting each year. Several pharmacological interventions meant to relieve such impactions have been explored; none have proven superior. OBJECTIVES: Perform a single-arm feasibility study of oral nitroglycerin solution for EFI. METHODS: Twenty adult patients presenting to a single urban tertiary medical centre thought to have EFI were given up to three doses of 0.4 mg nitroglycerin solution orally and evaluated for resolution of symptoms, new symptoms and vital signs. Patients with intractable vomiting, haemodynamic instability, airway compromise, oesophageal perforation, coronary ischaemia or presentation delayed greater than 12 hours were excluded. RESULTS: 17 of 20 enrolled subjects received the intervention. The average duration of symptoms prior to intervention was 285 min (SD=187). Four subjects did not tolerate the intervention (inability to swallow or headache). Two of 17 (11.8%) subjects obtained temporally proximal symptom resolution: 11 min after the second dose, and 7 min after the third dose. Seven also received glucagon during their visit, with 0% temporally proximal symptom resolution. Fifteen underwent endoscopy, with food bolus identified in 12. One subject had brief and mild hypotension with spontaneous resolution. Two subjects developed a headache after nitroglycerin administration. The median length of stay for those who found relief without endoscopy was 195 min (range 129-261) vs 374 min (range 122-525) among those with endoscopy. CONCLUSION: The observed rate of relief after oral nitroglycerin solution for EFI is disappointing but comparable to previous glucagon, benzodiazepines and effervescent beverage studies, and that of placebo. Oral nitroglycerin solution appears to be well tolerated among those able to swallow, although in our sample several subjects were unable to tolerate swallowing entirely.


Subject(s)
Esophagus , Foreign Bodies/drug therapy , Nitroglycerin/administration & dosage , Adult , Feasibility Studies , Female , Food , Humans , Male , Middle Aged , Pilot Projects , Prospective Studies , Solutions
17.
BMJ Case Rep ; 12(4)2019 Apr 29.
Article in English | MEDLINE | ID: mdl-31036742

ABSTRACT

Foreign bodies are commonly seen by the Ear, Nose and Throat emergency team with cotton wool being the most common aural foreign body seen in the adult population. Most complications secondary to aural foreign bodies described in the literature are minor and rarely require any surgical intervention. Here, we present two cases with impacted cotton wool as aural foreign bodies which resulted in suppurative labyrinthitis and osteomyelitis causing profound sensorineural hearing. These cases highlight the importance of considering aural foreign bodies in the differential diagnosis in those presenting with unilateral symptoms as significant complications, although rare, can occur, particularly in those with delayed diagnosis.


Subject(s)
Ear Canal/microbiology , Ear Diseases/microbiology , Foreign Bodies/complications , Hearing Loss, Sensorineural/etiology , Otitis Media, Suppurative/diagnosis , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Diagnosis, Differential , Ear Canal/pathology , Ear Diseases/drug therapy , Ear Diseases/pathology , Ear Diseases/surgery , Female , Foreign Bodies/diagnosis , Foreign Bodies/drug therapy , Foreign Bodies/surgery , Hearing Loss, Sensorineural/diagnosis , Humans , Labyrinthitis/microbiology , Magnetic Resonance Imaging/methods , Male , Mastoid/diagnostic imaging , Mastoid/pathology , Middle Aged , Osteomyelitis/diagnosis , Osteomyelitis/etiology , Otitis Media, Suppurative/etiology , Treatment Outcome
18.
Pharmacotherapy ; 39(4): 463-472, 2019 04.
Article in English | MEDLINE | ID: mdl-30779190

ABSTRACT

Glucagon is frequently used for the relief of esophageal impactions. This systematic review and meta-analysis were performed to evaluate the efficacy and safety of glucagon for acute esophageal foreign body and food impactions. PubMed, CINAHL, Latin American and Caribbean Health Sciences Literature (LILACS), Scopus, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials were searched from inception to March 1, 2018. Retrospective, observational, and randomized controlled trials assessing glucagon for the relief of acute esophageal foreign body and food impaction were included. There were no language or age restrictions. Only studies conducted on humans and with a comparator (e.g., control or placebo) were included. Study quality analysis was performed using the Cochrane Risk of Bias tool. Quality of evidence analysis was performed using the Grading of Recommendations, Assessment, Development and Evaluations approach. A total of 1988 studies were identified, and five studies with a total of 1185 subjects were included. Treatment success occurred in 213 of 706 (30.2%) patients in the glucagon group and 158 of 479 (33.0%) patients in the control group (odds ratio [OR] 0.90, 95% confidence interval [CI] 0.69-1.17, p=0.42). There was minimal statistical heterogeneity (I2  = 14%, p=0.33). No publication bias was identified. Adverse events were identified in 24 (15.0%) patients in the glucagon group and 0 (0%) patients in the placebo group (risk difference [RD] 0.18, 95% CI 0.03-0.33, p=0.02). Vomiting events occurred more frequently in the glucagon group (17 of 160 [10.6%] vs 0 of 53 [0%]) but was not statistically significant (RD 0.07, 95% CI -0.03-0.17, p=0.19). Glucagon was not associated with a difference in treatment success but had a higher rate of adverse events for the treatment of esophageal foreign body and food impaction. Further controlled studies are needed to confirm the efficacy of glucagon with adequate power to assess adverse events.


Subject(s)
Esophagus/drug effects , Foreign Bodies/drug therapy , Gastrointestinal Agents/therapeutic use , Glucagon/therapeutic use , Bezoars/drug therapy , Gastrointestinal Agents/administration & dosage , Gastrointestinal Agents/adverse effects , Glucagon/administration & dosage , Glucagon/adverse effects , Humans , Peristalsis/drug effects , Treatment Outcome
19.
Biomaterials ; 188: 144-159, 2019 01.
Article in English | MEDLINE | ID: mdl-30343257

ABSTRACT

The use of intracortical microelectrode arrays has gained significant attention in being able to help restore function in paralysis patients and study the brain in various neurological disorders. Electrode implantation in the cortex causes vasculature or blood-brain barrier (BBB) disruption and thus elicits a foreign body response (FBR) that results in chronic inflammation and may lead to poor electrode performance. In this study, a comprehensive insight into the acute molecular mechanisms occurring at the Utah electrode array-tissue interface is provided to understand the oxidative stress, neuroinflammation, and neurovascular unit (astrocytes, pericytes, and endothelial cells) disruption that occurs following microelectrode implantation. Quantitative real time polymerase chain reaction (qRT-PCR) was used to quantify the gene expression at acute time-points of 48-hr, 72-hr, and 7-days for factors mediating oxidative stress, inflammation, and BBB disruption in rats implanted with a non-functional 4 × 4 Utah array in the somatosensory cortex. During vascular disruption, free iron released into the brain parenchyma can exacerbate the FBR, leading to oxidative stress and thus further contributing to BBB degradation. To reduce the free iron released into the brain tissue, the effects of an iron chelator, deferoxamine mesylate (DFX), was also evaluated.


Subject(s)
Blood-Brain Barrier/pathology , Deferoxamine/therapeutic use , Electrodes, Implanted/adverse effects , Foreign Bodies/drug therapy , Foreign Bodies/etiology , Iron Chelating Agents/therapeutic use , Animals , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Foreign Bodies/metabolism , Foreign Bodies/pathology , Inflammation/drug therapy , Inflammation/etiology , Inflammation/metabolism , Inflammation/pathology , Male , Oxidative Stress/drug effects , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...